Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

178
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
178
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

130
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
130
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

94
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
94
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

79
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
79
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Vaccine efficacy estimands and power considerations.

Statistical methods in medical research·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Mortality-weighted severe maternal morbidity: a novel approach to assessing maternal health outcomes.

BMC pregnancy and childbirth·2025
Same author

Pair-Feeding Study Designs Can Create Biases and Inflate Type I Error Rates: A Simulation Study.

Obesity (Silver Spring, Md.)·2025

相关实验视频

Updated: Jul 17, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

多区域临床试验的贝叶斯联合模型

Nathan W Bean1, Joseph G Ibrahim1, Matthew A Psioda1

  • 1Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.

Biostatistics (Oxford, England)
|September 5, 2023
PubMed
概括

这项研究引入了一种新的贝叶斯联合建模方法,用于多区域临床试验 (MRCT). 这种方法通过借鉴跨地区的信息来提高全球治疗效应分析的统计能力.

科学领域:

  • 生物统计学 生物统计学
  • 临床试验方法论 临床试验方法论
  • 药学研究 药学研究

背景情况:

  • 多区域临床试验 (MRCT) 越来越多地用于加速全球药物开发.
  • 在MRCT的挑战包括小的区域样本大小,需要统计方法来获取信息,如ICH E17指南所建议的.
  • 现有的方法可能无法充分利用不同地区的可用数据.

研究的目的:

  • 开发和评估一种新的统计方法,用于在MRCT中联合分析存活率和纵向数据.
  • 在联合建模框架内使用贝叶斯模型平均值实现跨区域的信息借用.
  • 评估这种方法在改善全球治疗效应检测方面的表现.

主要方法:

  • 在MRCT的背景下,为时间到事件和纵向结果开发一个联合模型.
  • 贝叶斯模型的应用对跨区域信息借贷的平均值.
  • 使用拉普拉斯的方法对随机效应进行整合,并近似后部分布.
  • 进行模拟研究,将拟议的方法与传统的生存分析进行比较.

主要成果:

  • 拟议的联合建模方法表明,与模拟中单独分析生存数据相比,总体治疗效果的拒绝率增加.
  • 该方法有效地整合了生存和纵向数据,允许跨区域的信息共享.
关键词:
贝叶斯的临床试验 贝叶斯的临床试验贝叶斯模型的平均值是贝叶斯的模型.共同的模型 共同的模型这是一项LEADER试验.拉普拉斯的近似方法多区域临床试验多区域临床试验

更多相关视频

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

相关实验视频

Last Updated: Jul 17, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K
  • 成功应用到现实世界的心血管结果MRCT数据集.
  • 结论:

    • 贝叶斯联合建模与信息借用为分析MRCT数据提供了一个统计学上强大的方法.
    • 这种方法可以提高药物开发中全球治疗效果评估的效率和能力.
    • 该方法为优化未来MRCT的设计和分析提供了有价值的工具.